Araştırma Makalesi
BibTex RIS Kaynak Göster

Covid-19 ile ilişkili pnömoni şiddeti ile koagulopati ve mortalite arasındaki ilişki

Yıl 2021, Cilt: 46 Sayı: 2, 540 - 547, 30.06.2021
https://doi.org/10.17826/cumj.864023

Öz

Amaç: Çalışmamızda covid-19 ilişkili pnömoninin şiddetine bağlı olarak koagulasyon parametrelerinde oluşan değişim ile mortalitenin öngörülebilmesi araştırıldı.
Gereç ve Yöntem: Çalışmaya toplam 137 covid-19 nedenli pnömonisi bulunan hasta dahil edildi. Pnömoni şiddetine göre hastalar hafif, orta ve şiddetli olarak üç gruba ayrıldı. Pnömoni şiddetine göre tam kan sayımındaki parametreler ile biyokimyasal parametrelerin düzeyleri gruplar arasında karşılaştırıldı. Mortaliteye göre kan parametreleri incelenerek bu parametrelerin mortalite üzerine net etkisini belirlemek için ROC analizleri ve regresyon analizleri yapıldı.
Bulgular: Pnömoni şiddeti Protrombin zamanı (PTZ), International normalized ratio (INR) ve Aktive parsiyel tromboplastin zamanı (aPTT) değerlerinde artış kaydedilmiş olup PTZ ve INR değerlerinde gruplar arasında istatistiksel olarak anlamlı farklılık belirlenmiştir. Mortal seyreden olgularda PTZ, INR ve aPTT düzeylerinin daha yüksek olduğu belirlendi. Koagulasyon parametresinin (aPTT+PTZ) >45,1 saniye (sn) cut-off değerine göre 93,5% duyarlılık ve 97,5% özgüllükle belirlendi.
Sonuç: Covid-19 ilişkili pnömoni şiddetinin artışına ikincil olarak düzeyi yükselen koagulasyon parametresinin (aPTT+PTZ) mortalitenin öngörülmesinde başarılı sonuçlar sunduğu belirlenmiş olup klinik kullanımda önerebileceğimiz bir parametre olabilir.

Kaynakça

  • 1. WHO coronavirus disease (COVID-19) dashboard. Geneva: World Health Organization, 2020. Available online: https://covid19.who.int/ (last cited: [2020, November 30]).
  • 2. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020;323(18):1843-1844. doi:10.1001/jama.2020.3786.
  • 3. Li D, Wang D, Dong J, Wang N, Huang H, Xu H, et al. False-Negative Results of Real-Time Reverse-Transcriptase Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2: Role of Deep-Learning-Based CT Diagnosis and Insights from Two Cases. Korean J Radiol. 2020 Apr;21(4):505-508. doi: 10.3348/kjr.2020.0146.
  • 4. Pekçevik Y, Belet Ü. Patient Management in the Radiology Department, the Role of Chest Imaging During the SARS-CoV-2 Pandemic and Chest CT Findings Related to COVID-19 Pneumonia. Tepecik Eğit ve Araşt Hast Dergisi 2020;30(Ek sayı):195-212. doi: 10.5222/terh.2020.13549.
  • 5. Wan S, Yi Q, Fan S, Lv J, Zhang X, Guo L, et al. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). MedRxiv 2020. doi:10.1101/2020.02.10.20021832 (preprint).
  • 6. Yang Y, Shen C, Li J, Yuan J, Yang M, Wang F, et al. Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome. MedRxiv 2020.doi:10.1101/2020.03.02.20029975 (preprint).
  • 7. Mattiuzzi C, Lippi G. Which lessons shall we learn from the 2019 novel coronavirus outbreak? Ann Transl Med 2020;8(3):48.doi:10.21037/atm.2020.02.06.
  • 8. Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, et al. How COVID-19 induces cytokine storm with high mortality. Hojyo et al. Inflamm Regen (2020)40:37. https://doi.org/10.1186/s41232-020-00146-3.
  • 9. Ramana CV, DeBerge MP, Kumar A, Alia CS, Durbin JE, Enelow RI. Inflammatory impact of IFN‐γ in CD8+T cellmediated lung injury is mediated by both Stat1‐dependent and‐independent pathways. Am J Physiol Lung Cell Mol Physiol 2015;308(7):L650‐L657.doi:10.1152/ajplung.00360.2014.
  • 10. Schwarze J, Cieslewicz G, Joetham A, Ikemura T, Hamelmann E, Gelfand EW. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J Immunol 1999; 162: 4207-11. PMID:10201948.
  • 11. Musher DM, Abers MS, Corrales-Medina VF. Acute Infection and Myocardial Infarction. N Engl J Med 2019; 380:171-176. doi: 10.1056/NEJMra1808137.
  • 12. Lv X, Wang H. Pathophysiology of sepsis-induced myocardial dysfunction. Military Med Res (2016) 3:30. doi: 10.1186/s40779-016-0099-9.
  • 13. Simmons J, Pittet J-F. The Coagulopathy of Acute Sepsis. Curr Opin Anaesthesiol. 2015 April;28(2): 227–236. doi:10.1097/ACO.0000000000000163.
  • 14. Lee AYY, Connors JM, Kreuziger LB, Murphy M, Gernsheimer T, Lin Y, et al. COVID-19 and Coagulopathy: Frequently Asked Questions (Version 7.0; last updated January 29, 2021). Amerıcan Society of Hematology. 2021. Available at; https://www.hematology.org/covid-19/covid-19-and-coagulopathy.
  • 15. Yazici O, Bozkuş F, Demirci N, Gülhan PY, Coşkun F. Coagulopathy and COVID-19. Eurasian J Pulmonol 2020;22(Suppl S1):67-9. doi: 10.4103/ejop.ejop_49_20.
  • 16. Rostami M, Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol. 2020;13(11):1265-1275. doi: 10.1080/17474086.2020.1831383.
  • 17. Elshazli RM, Toraih EA, Elgaml A, El-Mowafy M, El-Mesery M, Amin MN, et al. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PLoS One. 2020 Aug 21;15(8):e0238160. doi: 10.1371/journal.pone.0238160.

Relationship between Covid-19-associated pneumonia severity with coagulopathy and mortality

Yıl 2021, Cilt: 46 Sayı: 2, 540 - 547, 30.06.2021
https://doi.org/10.17826/cumj.864023

Öz

Purpose: In the present study, the possibility of predicting mortality with the change in coagulation parameters depending on the severity of Covid-19-associated pneumonia was investigated.
Materials and Methods: A total of 137 patients with Covid-19-associated pneumonia were included in the study. The patients were divided into three groups according to the severity of pneumonia as mild, moderate and severe. According to the severity of pneumonia, the parameters of complete blood count and the levels of biochemical parameters were compared between the groups. By examining blood parameters according to mortality, ROC analysis and regression analysis were performed to determine the net effect of these parameters on mortality.
Results: As the severity of pneumonia increased, Prothrombin time (PT), International normalized ratio (INR) and Activated partial thromboplastin time (aPTT) values were also increased, and a statistically significant difference was found between the groups in PT and INR values. PT, INR and aPTT levels were higher in cases with mortality. Mortality can be predicted with 93.5% sensitivity and 97.5% specificity. according to the >45.1 seconds(sec) cut-off value of the coagulation parameter (aPTT+PT.
Conclusion: The coagulation parameter (aPTT + PT), whose level increases secondarily to the increase in Covid-19-associated pneumonia severity, provides successful results in predicting mortality, and may be a parameter that we can recommend in clinical use.

Kaynakça

  • 1. WHO coronavirus disease (COVID-19) dashboard. Geneva: World Health Organization, 2020. Available online: https://covid19.who.int/ (last cited: [2020, November 30]).
  • 2. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020;323(18):1843-1844. doi:10.1001/jama.2020.3786.
  • 3. Li D, Wang D, Dong J, Wang N, Huang H, Xu H, et al. False-Negative Results of Real-Time Reverse-Transcriptase Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2: Role of Deep-Learning-Based CT Diagnosis and Insights from Two Cases. Korean J Radiol. 2020 Apr;21(4):505-508. doi: 10.3348/kjr.2020.0146.
  • 4. Pekçevik Y, Belet Ü. Patient Management in the Radiology Department, the Role of Chest Imaging During the SARS-CoV-2 Pandemic and Chest CT Findings Related to COVID-19 Pneumonia. Tepecik Eğit ve Araşt Hast Dergisi 2020;30(Ek sayı):195-212. doi: 10.5222/terh.2020.13549.
  • 5. Wan S, Yi Q, Fan S, Lv J, Zhang X, Guo L, et al. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). MedRxiv 2020. doi:10.1101/2020.02.10.20021832 (preprint).
  • 6. Yang Y, Shen C, Li J, Yuan J, Yang M, Wang F, et al. Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome. MedRxiv 2020.doi:10.1101/2020.03.02.20029975 (preprint).
  • 7. Mattiuzzi C, Lippi G. Which lessons shall we learn from the 2019 novel coronavirus outbreak? Ann Transl Med 2020;8(3):48.doi:10.21037/atm.2020.02.06.
  • 8. Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, et al. How COVID-19 induces cytokine storm with high mortality. Hojyo et al. Inflamm Regen (2020)40:37. https://doi.org/10.1186/s41232-020-00146-3.
  • 9. Ramana CV, DeBerge MP, Kumar A, Alia CS, Durbin JE, Enelow RI. Inflammatory impact of IFN‐γ in CD8+T cellmediated lung injury is mediated by both Stat1‐dependent and‐independent pathways. Am J Physiol Lung Cell Mol Physiol 2015;308(7):L650‐L657.doi:10.1152/ajplung.00360.2014.
  • 10. Schwarze J, Cieslewicz G, Joetham A, Ikemura T, Hamelmann E, Gelfand EW. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J Immunol 1999; 162: 4207-11. PMID:10201948.
  • 11. Musher DM, Abers MS, Corrales-Medina VF. Acute Infection and Myocardial Infarction. N Engl J Med 2019; 380:171-176. doi: 10.1056/NEJMra1808137.
  • 12. Lv X, Wang H. Pathophysiology of sepsis-induced myocardial dysfunction. Military Med Res (2016) 3:30. doi: 10.1186/s40779-016-0099-9.
  • 13. Simmons J, Pittet J-F. The Coagulopathy of Acute Sepsis. Curr Opin Anaesthesiol. 2015 April;28(2): 227–236. doi:10.1097/ACO.0000000000000163.
  • 14. Lee AYY, Connors JM, Kreuziger LB, Murphy M, Gernsheimer T, Lin Y, et al. COVID-19 and Coagulopathy: Frequently Asked Questions (Version 7.0; last updated January 29, 2021). Amerıcan Society of Hematology. 2021. Available at; https://www.hematology.org/covid-19/covid-19-and-coagulopathy.
  • 15. Yazici O, Bozkuş F, Demirci N, Gülhan PY, Coşkun F. Coagulopathy and COVID-19. Eurasian J Pulmonol 2020;22(Suppl S1):67-9. doi: 10.4103/ejop.ejop_49_20.
  • 16. Rostami M, Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol. 2020;13(11):1265-1275. doi: 10.1080/17474086.2020.1831383.
  • 17. Elshazli RM, Toraih EA, Elgaml A, El-Mowafy M, El-Mesery M, Amin MN, et al. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PLoS One. 2020 Aug 21;15(8):e0238160. doi: 10.1371/journal.pone.0238160.
Toplam 17 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Solunum Hastalıkları
Bölüm Araştırma
Yazarlar

Begüm Şeyda Avci 0000-0001-6149-9341

Adem Kaya Bu kişi benim 0000-0001-9529-1354

Hilmi Erdem Sümbül 0000-0002-7192-0280

Ferhat İçme 0000-0001-5180-7152

Hasan Yeşilağaç 0000-0002-1365-9256

Nevzat Ünal Bu kişi benim 0000-0001-5121-3100

Önder Yeşiloğlu 0000-0003-0149-8456

Hayri Çınar Bu kişi benim 0000-0001-8645-3083

Tuba Turunç Bu kişi benim 0000-0002-0722-6964

Yayımlanma Tarihi 30 Haziran 2021
Kabul Tarihi 19 Şubat 2021
Yayımlandığı Sayı Yıl 2021 Cilt: 46 Sayı: 2

Kaynak Göster

MLA Avci, Begüm Şeyda vd. “Relationship Between Covid-19-Associated Pneumonia Severity With Coagulopathy and Mortality”. Cukurova Medical Journal, c. 46, sy. 2, 2021, ss. 540-7, doi:10.17826/cumj.864023.